HideChilds = False
SystemName = Homepage

Bioverativ – A new era of impact

A new era of impact

We’re dedicated to creating meaningful progress for people with hemophilia and other rare blood disorders.

Learn more

Science that redefines what's possible

Our scientists brought the first major advances in hemophilia treatment in nearly two decades, and we’re committed to developing new, life-changing medicines for people with rare blood disorders.

Learn more

Guided by our dedication to community

Working in partnership with patients, physicians, caregivers, and advocates, we aim to improve access to treatment, advance disease understanding and transform lives.

Learn more

Bioverativ in the news

Tuesday, May 23, 2017 7:00 AM

Bioverativ to Acquire Clinical-Stage Rare Disease Biotechnology Company, True North Therapeutics

Read more